New Rosacea Treatments

One of the hottest areas of interest online for rosacea sufferers is new rosacea treatments. From the industry heavyweights like Galderma, Allergan, Bayer, Valeant and Stiefel to little companies like MooGoo there is a lot of interest in the up and coming rosacea treatments. See below for the latest information about what is just over the horizon.

Recent Rosacea Blog Posts

Epsolay is Sol-Gel’s Benzoyl Peroxide for Rosacea

A new treatment for the papules and pustules of rosacea has been given its product name. Publicity surrounding the trial of the new benzoyl peroxide based rosacea topical has mentioned that the product is to be called Epsolay. Previously Epsolay has been known as VERED, S5G4T-1 and DER 45 EV. It is encouraging that Epsolay has […]

Continue Reading

Sol-Gel’s S5G4T-1 benzoyl peroxide cream for papules and pustules

Described in the official trial only as a “topical cream”, Sol-Gel are undergoing a Phase 3 trial for a product newly designated as S5G4T-1. What is S5G4T-1? Although the clinical trial listing doesn’t provide any details about the components of S5G4T-1, their own web site reveals more information. Based on Sol-Gel’s product portfolio, it seems clear that S5G4T-1 is […]

Continue Reading

Sarecycline for acne and rosacea

I don’t know if rosacea sufferers really need another tetracycline variant, but Allergan has published some promising Phase III trial data for Sarecycline as a treatment for the lesions of moderate to severe acne. Whilst no longer being directly promoted as a treatment for rosacea (and indeed it is not clear if Allergan will be […]

Continue Reading

Accuitis to trial ACU-D1 for Rosacea

A drug that is said to inhibit nuclear factor kappa beta (NFkB), is to be trialed as a rosacea treatment. The new treatment, code named ACU-D1 will be tested as a treatment primarily for the papules and pustules of rosacea. Clinical Trial NCT03064438 Efficacy of Accu-D1 in the Treatment of Acne Rosacea The study evaluates the safety, […]

Continue Reading

Dermata DMT 210 works for redness and bumps of rosacea

A press release today highlighting a new drug, based on Arazine, that is claimed to help both the redness and papules and pustules of rosacea through its ability to down regulate G-protein coupled receptor (GPCR) signaling. The company developing DMT 210, Dermata, is releasing results from their phase 1 trials, and are looking to commence phase 2 trials […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.